Sagimet Biosciences Ownership & Insider Activity

Sagimet Biosciences (SGMT) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.9% of shares outstanding. Institutional investors hold 30.4%.

Shares Outstanding

70.909M

Shares Float

69.818M

Insider Shares Owned

1.348M

Insider % Owned

1.9%

Institutional Shares Held

21.554M

Institutional % Held

30.4%

Ownership Breakdown

Net Insider Activity by Month

Sagimet Biosciences Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Aug 14, 2026	George Kemble	—	SELL-OPTIONS	—	$8.30	$1.4M
Aug 11, 2026	George Kemble	—	SELL-OPTIONS	—	$8.16	$73K
Jul 20, 2026	David Happel	PRESIDENT & CEO	SELL	64.051K	$7.76	$497K
Jul 20, 2026	Elizabeth Rozek	CHIEF LEGAL & ADMIN. OFFICER	SELL	10.545K	$7.76	$82K
Jul 20, 2026	George Kemble	—	SELL	18.844K	$7.46	$141K